Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mol Cancer Res. 2003 Oct;1(12):903-12.
Mol Cancer Res. 2003.
PMID: 14573791
The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters.
Nudelman A, Levovich I, Cutts SM, Phillips DR, Rephaeli A.
Nudelman A, et al. Among authors: levovich i.
J Med Chem. 2005 Feb 24;48(4):1042-54. doi: 10.1021/jm049428p.
J Med Chem. 2005.
PMID: 15715472
Item in Clipboard
In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.
Rephaeli A, Blank-Porat D, Tarasenko N, Entin-Meer M, Levovich I, Cutts SM, Phillips DR, Malik Z, Nudelman A.
Rephaeli A, et al. Among authors: levovich i.
Int J Cancer. 2005 Aug 20;116(2):226-35. doi: 10.1002/ijc.21030.
Int J Cancer. 2005.
PMID: 15800932
Free article.
Item in Clipboard
Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7/Dx cell lines.
Engel D, Nudelman A, Levovich I, Gruss-Fischer T, Entin-Meer M, Phillips DR, Cutts SM, Rephaeli A.
Engel D, et al. Among authors: levovich i.
J Cancer Res Clin Oncol. 2006 Oct;132(10):673-83. doi: 10.1007/s00432-006-0116-6. Epub 2006 Jul 7.
J Cancer Res Clin Oncol. 2006.
PMID: 16826403
Item in Clipboard
Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
Cutts SM, Nudelman A, Pillay V, Spencer DM, Levovich I, Rephaeli A, Phillips DR.
Cutts SM, et al. Among authors: levovich i.
Oncol Res. 2005;15(4):199-213. doi: 10.3727/096504005776382305.
Oncol Res. 2005.
PMID: 17822280
Item in Clipboard
Formaldehyde-releasing prodrugs specifically affect cancer cells by depletion of intracellular glutathione and augmentation of reactive oxygen species.
Levovich I, Nudelman A, Berkovitch G, Swift LP, Cutts SM, Phillips DR, Rephaeli A.
Levovich I, et al.
Cancer Chemother Pharmacol. 2008 Aug;62(3):471-82. doi: 10.1007/s00280-007-0627-0. Epub 2007 Nov 21.
Cancer Chemother Pharmacol. 2008.
PMID: 18030472
Item in Clipboard
Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D, Nudelman A, Tarasenko N, Levovich I, Makarovsky I, Sochotnikov S, Tarasenko I, Rephaeli A.
Engel D, et al. Among authors: levovich i.
J Med Chem. 2008 Jan 24;51(2):314-23. doi: 10.1021/jm7009827. Epub 2007 Dec 29.
J Med Chem. 2008.
PMID: 18163551
Item in Clipboard
The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP, Cutts SM, Nudelman A, Levovich I, Rephaeli A, Phillips DR.
Swift LP, et al. Among authors: levovich i.
Cancer Chemother Pharmacol. 2008 Apr;61(5):739-49. doi: 10.1007/s00280-007-0528-2. Epub 2007 Jun 27.
Cancer Chemother Pharmacol. 2008.
PMID: 17594094
Item in Clipboard
Cite
Cite